Mucosal-Associated Invariant T cell in liver diseases
- PMID: 32015682
- PMCID: PMC6990906
- DOI: 10.7150/ijbs.39016
Mucosal-Associated Invariant T cell in liver diseases
Abstract
Mucosal-associated invariant T cells (MAIT cells) are a new population of innate immune cells, which are abundant in the liver and play complex roles in various liver diseases. In this review, we summarize MAIT cells in the liver diseases in recent studies, figure out the role of MAIT cells in various liver disease, including Alcoholic liver disease, Non-alcoholic liver disease, Autoimmune liver diseases, Viral hepatitis and Liver Cancer. Briefly, MAIT cells are involved in anti-bacteria responses in the alcoholic liver diseases. Besides, the activated MAIT cells promote the liver inflammation by secreting inflammatory cytokines and produce regulatory cytokines, which induces anti-inflammatory macrophage polarization. MAIT cells participate in the liver fibrosis via enhancing hepatic stellate cell activation. In viral hepatitis, MAIT cells exhibit a flawed and exhausted phenotype, which results in little effect on controlling the virus and bacteria. In liver cancer, MAIT cells indicate the disease progression and the outcome of therapy. In summary, MAIT cells are attractive biomarkers and therapeutic targets for liver disease.
Keywords: MAIT cells; alcoholic liver disease; autoimmune liver disease; liver cancer; non-alcoholic liver disease.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures


Similar articles
-
Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease.Gut. 2018 May;67(5):918-930. doi: 10.1136/gutjnl-2017-314458. Epub 2017 Nov 2. Gut. 2018. PMID: 29097439 Free PMC article.
-
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation.Hepatology. 2018 Jul;68(1):172-186. doi: 10.1002/hep.29782. Epub 2018 May 9. Hepatology. 2018. PMID: 29328499
-
Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.Front Immunol. 2018 Sep 4;9:1994. doi: 10.3389/fimmu.2018.01994. eCollection 2018. Front Immunol. 2018. PMID: 30233587 Free PMC article.
-
Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases.Immunol Cell Biol. 2018 Jul;96(6):618-629. doi: 10.1111/imcb.12011. Epub 2018 Mar 2. Immunol Cell Biol. 2018. PMID: 29405379 Review.
-
Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.World J Gastroenterol. 2021 Jul 7;27(25):3705-3733. doi: 10.3748/wjg.v27.i25.3705. World J Gastroenterol. 2021. PMID: 34321839 Free PMC article. Review.
Cited by
-
Chronic viral infection compromises the quality of circulating mucosal-invariant T cells and follicular T helper cells via expression of both activating and inhibitory receptors.Res Sq [Preprint]. 2023 Apr 27:rs.3.rs-2862719. doi: 10.21203/rs.3.rs-2862719/v1. Res Sq. 2023. Update in: Front Biosci (Landmark Ed). 2024 Mar 22;29(3):128. doi: 10.31083/j.fbl2903128. PMID: 37163092 Free PMC article. Updated. Preprint.
-
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact.Hepatol Int. 2024 Oct;18(Suppl 2):861-872. doi: 10.1007/s12072-024-10674-6. Epub 2024 Jul 12. Hepatol Int. 2024. PMID: 38995341 Review.
-
Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development.Int J Mol Sci. 2020 Jul 19;21(14):5097. doi: 10.3390/ijms21145097. Int J Mol Sci. 2020. PMID: 32707678 Free PMC article. Review.
-
Early activation and recruitment of invariant natural killer T cells during liver ischemia-reperfusion: the major role of the alarmin interleukin-33.Front Immunol. 2023 May 9;14:1099529. doi: 10.3389/fimmu.2023.1099529. eCollection 2023. Front Immunol. 2023. PMID: 37228593 Free PMC article.
-
Reduced Energy Metabolism Impairs T Cell-Dependent B Cell Responses in Patients With Advanced HBV-Related Cirrhosis.Front Immunol. 2021 Jun 23;12:660312. doi: 10.3389/fimmu.2021.660312. eCollection 2021. Front Immunol. 2021. PMID: 34248941 Free PMC article.
References
-
- Balmer M L, Slack E, de Gottardi A. et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med. 2014;6:237r–266r. - PubMed
-
- Tang X Z, Jo J, Tan A T. et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol. 2013;190:3142–3152. - PubMed
-
- Kjer-Nielsen L, Patel O, Corbett A J. et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491:717–723. - PubMed
-
- Treiner E, Duban L, Bahram S. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422:164–169. - PubMed
-
- Franciszkiewicz K, Salou M, Legoux F. et al. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells. Immunol Rev. 2016;272:120–138. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical